We are live on ! Find out more
GTC

Ghost Tree Capital Portfolio holdings

AUM $331M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
+23.45%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$208M
AUM Growth
+$24.2M
Cap. Flow
+$3.02M
Cap. Flow %
1.45%
Top 10 Hldgs %
36.52%
Holding
103
New
33
Increased
10
Reduced
10
Closed
44

Top Buys

1
WMGI
Wright Medical Group Inc
WMGI
+$6.88M
2
GILD icon
Gilead Sciences
GILD
+$6.72M
3
PBYI icon
Puma Biotechnology
PBYI
+$5.55M
4
CPHD
Cepheid Inc
CPHD
+$5.06M
5
AVDL
Avadel Pharmaceuticals
AVDL
+$4.64M

Top Sells

1
CYH icon
Community Health Systems
CYH
+$5.48M
2
TRNX
TORNIER N V SHARES (NLD)
TRNX
+$4.78M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$4.49M
4
AGN
Allergan Inc
AGN
+$4.46M
5
HCA icon
HCA Healthcare
HCA
+$4.23M

Sector Composition

1 Healthcare 69%
2 Technology 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
CALL
Gilead Sciences
GILD
$167B
$11.8M 5.65%
+125,000
New +$12.9M
ZBH icon
2
Zimmer Biomet
ZBH
$17.6B
$9.78M 4.69%
88,786
+37,286
+72% +$3.93M
SYK icon
3
CALL
Stryker
SYK
$123B
$9.43M 4.53%
+100,000
New +$8.87M
IONS icon
4
CALL
Ionis Pharmaceuticals
IONS
$8.99B
$9.26M 4.44%
+150,000
New +$7.4M
ADVM
5
DELISTED
Adverum Biotechnologies
ADVM
$6.75M 3.24%
12,500
+7,500
+150% +$2.89M
WMGI
6
DELISTED
Wright Medical Group Inc
WMGI
$6.31M 3.03%
+235,000
New +$6.88M
GILD icon
7
Gilead Sciences
GILD
$167B
$6.13M 2.94%
+65,000
New +$6.72M
PBYI icon
8
Puma Biotechnology
PBYI
$434M
$5.68M 2.72%
30,000
+25,000
+500% +$5.55M
AVDL
9
DELISTED
Avadel Pharmaceuticals
AVDL
$5.57M 2.67%
+325,000
New +$4.64M
CPHD
10
DELISTED
Cepheid Inc
CPHD
$5.41M 2.6%
+100,000
New +$5.06M
ALNY icon
11
Alnylam Pharmaceuticals
ALNY
$35.7B
$5.33M 2.56%
55,000
+20,000
+57% +$1.85M
LJPC
12
DELISTED
La Jolla Pharmaceutical Company
LJPC
$5.28M 2.53%
+286,053
New +$3.4M
ASRT
13
DELISTED
Assertio
ASRT
$4.83M 2.32%
5,000
+3,000
+150% +$2.74M
DYAX
14
DELISTED
DYAX CORPORATION
DYAX
$4.57M 2.19%
+325,000
New +$4.07M
AGN
15
DELISTED
Allergan plc
AGN
$4.5M 2.16%
17,500
+2,500
+17% +$625K
ZLTQ
16
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$4.47M 2.14%
160,000
-15,000
-9% -$391K
NVRO
17
DELISTED
NEVRO CORP.
NVRO
$4.45M 2.13%
+115,000
New +$3.62M
PTCT icon
18
PTC Therapeutics
PTCT
$6.52B
$4.4M 2.11%
85,000
+35,000
+70% +$1.54M
PTLA
19
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$4.25M 2.04%
150,000
+35,000
+30% +$973K
NUVA
20
DELISTED
NuVasive, Inc.
NUVA
$4.24M 2.04%
90,000
+40,000
+80% +$1.67M
INSY
21
DELISTED
Insys Therapeutics, Inc.
INSY
$4.22M 2.02%
+200,000
New +$3.95M
HZNP
22
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.87M 1.86%
300,000
-125,000
-29% -$1.56M
AIRM
23
DELISTED
Air Methods Corp
AIRM
$3.74M 1.8%
+85,000
New +$3.98M
BMRN icon
24
BioMarin Pharmaceuticals
BMRN
$11.5B
$3.62M 1.74%
+40,000
New +$3.33M
KITE
25
DELISTED
Kite Pharma, Inc.
KITE
$3.46M 1.66%
+60,000
New +$2.53M
1
2 3 4 5

Similar funds

SF
Susquehanna Foundation Bala Cynwyd, Pennsylvania $333M AUM 35.73% 1-Year Est. Return
AFS
Annapolis Financial Services Annapolis, Maryland $338M AUM 23.49% 1-Year Est. Return
SFA
Source Financial Advisors New York $338M AUM 33.62% 1-Year Est. Return
E
ETFidea Syracuse, New York $316M AUM 29.57% 1-Year Est. Return
OHCM
Oak Hill Capital Management New York $310M AUM 17.23% 1-Year Est. Return
MC
Minot Capital Broomfield, Colorado $353M AUM 25.25% 1-Year Est. Return
BRA
Biechele Royce Advisors Fishers, Indiana $303M AUM 20.64% 1-Year Est. Return
S
Syntrinsic Denver, Colorado $301M AUM 27.27% 1-Year Est. Return

Ghost Tree Capital's Q4 2014 Portfolio in Review

As of Q4 2014, Ghost Tree Capital held 103 positions worth $208M, up 13% from $184M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Ghost Tree Capital's Q4 2014 filing shows 33 new, 10 increased, 10 reduced and 44 closed positions. Its largest new stake was Wright Medical Group Inc: 235,000 shares worth $6.31M. The largest sale was Community Health Systems, an estimated $5.48M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 63% a quarter earlier, followed by Technology.

  • Ghost Tree Capital's largest Q4 2014 buy was Wright Medical Group Inc: 235,000 shares worth $6.31M.
  • Ghost Tree Capital added most to Puma Biotechnology in Q4 2014, an estimated $5.55M increase.
  • Ghost Tree Capital's biggest Q4 2014 reduction was AtriCure, cutting an estimated $2.57M.
  • Ghost Tree Capital fully exited Community Health Systems in Q4 2014, selling an estimated $5.48M.
  • Ghost Tree Capital's ten largest holdings make up 37% of its $208M portfolio in Q4 2014.
  • Ghost Tree Capital opened 33 new positions and closed 44 in Q4 2014.
  • Ghost Tree Capital's portfolio value rose 13% quarter-over-quarter to $208M.

Based on Ghost Tree Capital's 13F filing for Q4 2014, filed 17 Feb 2015.